UASt regulatory sequences drive expression of an inverted repeat.
Compared to one parental control (though not the other), expression of ND51GD5335 via Scer\GAL4elav-C155 causes increased agressive behaviour (lunging assay) in 4-6 day-old male flies. Expression via Scer\GAL4repo does not cause increased agressive behaviour.
Adults expressing ND-51GD5335 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.
Expression of CG9140GD5335 under the control of Scer\GAL4da.Switch.PT in the presence of 20μ/ml RU486 results in lethality.
Expression of CG9140GD5335 under the control of Scer\GAL4da.Switch.PT in the presence of 1μ/ml RU486 results in a prolonged developmental phase compared to controls.
Expression of CG9140GD5335 under the control of Scer\GAL4da.Switch.PT in the presence of 1μ/ml RU486 does not result in a significant change in body weight in male flies.
Expression of CG9140GD5335 under the control of Scer\GAL4da.Switch.PT in the presence of 1μ/ml RU486 does not have a significant effect on adult lifespan.
Expression under the control of Scer\GAL4Mef2.PR results in early pupal lethality.
Expression under the control of Scer\GAL4pnr-MD237 may result in semi-lethality, depending on the insertion line used.
Expression under the control of Scer\GAL4pnr-MD237 results in loss of bristles on the notum in 0% or 20-30% of the Scer\GAL4pnr-MD237 expression domain, depending on the insertion line used.
Expression under the control of Scer\GAL4pnr-MD237 results in bristle morphology defects on the notum in 70-80% or 80-90% of the Scer\GAL4pnr-MD237 expression domain, depending on the insertion line used.
Expression under the control of Scer\GAL4pnr-MD237 results in the absence of 20-30% of the Scer\GAL4pnr-MD237-expressing area of the notum.